Further research, which separated the heterogeneous aPL population from APS patients into different subpopulations, showed that anti-β2GPI antibodies significantly enhanced the thrombotic response in a mouse model (36). This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.